{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:53:36Z","timestamp":1776729216744,"version":"3.51.2"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:00:00Z","timestamp":1742688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejps.2025.107081","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T05:22:59Z","timestamp":1742793779000},"page":"107081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Co-milling of glass forming ability class III drugs: Comparing the impact of low and high glass transition temperatures"],"prefix":"10.1016","volume":"209","author":[{"given":"Nicolas","family":"P\u00e4tzmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Ber\u00e1nek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan T.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kuentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-8364","authenticated-orcid":false,"given":"Patrick J.","family":"O'Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107081_bib0001","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.3390\/molecules27103085","article-title":"Self-nanoemulsifying drug delivery system (SNEDDS) of apremilast: in vitrovitro evaluation and pharmacokinetics studies","volume":"27","author":"Abushal","year":"2022","journal-title":"Molecules."},{"key":"10.1016\/j.ejps.2025.107081_bib0002","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1021\/jacs.0c03990","article-title":"From mechanical effects to mechanochemistry: softening and depression of the melting point of deformed plastic crystals","volume":"142","author":"Ahmed","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2025.107081_bib0003","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/mp500303a","article-title":"Computational predictions of glass-forming ability and crystallization tendency of drug molecules","volume":"11","author":"Alhalaweh","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107081_bib0004","first-page":"1207","article-title":"Premelting at defects within bulk colloidal crystals","volume":"309","author":"Alsayed","year":"2005","journal-title":"Science (1979)"},{"key":"10.1016\/j.ejps.2025.107081_bib0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/pharmaceutics12060483","article-title":"Influence of the polymer glass transition temperature and molecular weight on drug amorphization kinetics using ball milling","volume":"12","author":"Asgreen","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2025.107081_bib0006","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/pharmaceutics12060483","article-title":"Influence of the polymer glass transition temperature and molecular weight on drug amorphization kinetics using ball milling","volume":"12","author":"Asgreen","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2025.107081_bib0007","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1002\/jps.22197","article-title":"A classification system to assess the crystallization tendency of organic molecules from undercooled melts","volume":"99","author":"Baird","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107081_bib0008","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/jps.21998","article-title":"Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives","volume":"99","author":"Balani","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107081_bib0009","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.xphs.2020.10.055","article-title":"Applying computational predictions of biorelevant solubility ratio upon self-emulsifying lipid-based formulations dispersion to predict dose number","volume":"110","author":"Bennett-Lenane","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107081_bib0010","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.apsb.2021.05.014","article-title":"Pharmaceutical amorphous solid dispersion: a review of manufacturing strategies","volume":"11","author":"Bhujbal","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejps.2025.107081_bib0011","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/acs.molpharmaceut.6b00650","article-title":"Glass forming ability of amorphous drugs investigated by continuous cooling and isothermal transformation","volume":"13","author":"Blaabjerg","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107081_bib0012","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2017.02.042","article-title":"Influence of preparation pathway on the glass forming ability","volume":"521","author":"Blaabjerg","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107081_bib0013","article-title":"Mechanistic study of dissolution enhancement by interactive mixtures of chitosan with meloxicam as model","volume":"169","author":"Broke\u0161ov\u00e1","year":"2022","journal-title":"Euro. J. Pharmaceutic.Sci."},{"key":"10.1016\/j.ejps.2025.107081_bib0014","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejps.2005.08.013","article-title":"The effect of crystal morphology and mill type on milling induced crystal disorder","volume":"27","author":"Chikhalia","year":"2006","journal-title":"Euro. J. Pharmaceutic. Sci."},{"key":"10.1016\/j.ejps.2025.107081_bib0015","doi-asserted-by":"crossref","first-page":"8148","DOI":"10.1016\/j.jmrt.2020.05.080","article-title":"A critical review on the mechanisms of chemical additives used in grinding and their effects on the downstream processes","volume":"9","author":"Chipakwe","year":"2020","journal-title":"J. Mater. Res. Technol."},{"key":"10.1016\/j.ejps.2025.107081_bib0016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.addr.2016.01.011","article-title":"Perspectives on the amorphisation\/milling relationship in pharmaceutical materials","volume":"100","author":"Descamps","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107081_bib0017","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/jps.20939","article-title":"Transformation of pharmaceutical compounds upon milling and comilling: the role of tg","volume":"96","author":"Descamps","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107081_bib0018","article-title":"Developing an in vitro lipolysis model for real-time analysis of drug concentrations during digestion of lipid-based formulations","volume":"194","author":"Ejskj\u00e6r","year":"2024","journal-title":"Euro. J. Pharmaceutic. Sci."},{"key":"10.1016\/j.ejps.2025.107081_bib0019","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2013.10.016","article-title":"Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate","volume":"86","author":"Griffin","year":"2014","journal-title":"Euro. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.ejps.2025.107081_bib0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1248\/cpb.58.293","article-title":"Enhanced dissolution and bioavailability of raloxifene hydrochloride by Co-grinding with different superdisintegrants","volume":"58","author":"Jagadish","year":"2010","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejps.2025.107081_bib0021","doi-asserted-by":"crossref","DOI":"10.22146\/ijp.7072","article-title":"Co-milling: a successful approach to enhance solubility of a poorly soluble antihypertensive drug","author":"Kamil","year":"2023","journal-title":"Indon. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107081_bib0022","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejpb.2018.09.024","article-title":"In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine","volume":"132","author":"Kasten","year":"2018","journal-title":"Euro. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.ejps.2025.107081_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121174","article-title":"Predicting in vivo performance of fenofibrate amorphous solid dispersions using in vitro non-sink dissolution and dissolution permeation setup","volume":"610","author":"Lentz","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107081_bib0024","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevB.109.024109","article-title":"Experimental investigation of the premelting process in Sn","volume":"109","author":"Lipson","year":"2024","journal-title":"Phys. Rev. B"},{"key":"10.1016\/j.ejps.2025.107081_bib0025","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejpb.2013.03.026","article-title":"Amino acids as co-amorphous stabilizers for poorly water-soluble drugs \u2013 Part 2: molecular interactions","volume":"85","author":"L\u00f6bmann","year":"2013","journal-title":"Europ. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.ejps.2025.107081_bib0026","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/jps.21903","article-title":"Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis","volume":"99","author":"Murdande","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107081_bib0027","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1021\/acs.cgd.7b01664","article-title":"Using milling to explore physical states: the amorphous and polymorphic forms of dexamethasone","volume":"18","author":"Oliveira","year":"2018","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2025.107081_bib0028","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijpharm.2006.11.030","article-title":"Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling","volume":"336","author":"Patterson","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107081_bib0029","article-title":"Predictive computational models for assessing the impact of co-milling on drug dissolution","volume":"198","author":"P\u00e4tzmann","year":"2024","journal-title":"Euro. J. Pharmaceut. Sciences"},{"key":"10.1016\/j.ejps.2025.107081_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.addr.2015.12.014","article-title":"Unintended and in situ amorphisation of pharmaceuticals","volume":"100","author":"Priemel","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107081_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120312","article-title":"Effect of co-milling on dissolution rate of poorly soluble drugs","volume":"597","author":"Sl\u00e1mov\u00e1","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107081_bib0032","doi-asserted-by":"crossref","first-page":"7411","DOI":"10.1021\/acs.analchem.9b01378","article-title":"Direct measurement of amorphous solubility","volume":"91","author":"\u0160tukelj","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejps.2025.107081_bib0033","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1021\/acs.molpharmaceut.8b00206","article-title":"Polymeric precipitation inhibitors promote fenofibrate supersaturation and enhance drug absorption from a type IV lipid-based formulation","volume":"15","author":"Suys","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107081_bib0034","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1021\/acs.cgd.5b00956","article-title":"A new low melting-point polymorph of fenofibrate prepared via Talc induced heterogeneous nucleation","volume":"15","author":"Tipduangta","year":"2015","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2025.107081_bib0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijpharm.2017.09.062","article-title":"Improving the wetting and dissolution of ibuprofen using solventless co-milling","volume":"533","author":"Varghese","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107081_bib0036","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejpb.2007.06.011","article-title":"Cogrinding enhances the oral bioavailability of EMD 57033, a poorly water soluble drug, in dogs","volume":"68","author":"Vogt","year":"2008","journal-title":"Euro. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.ejps.2025.107081_bib0037","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejpb.2007.06.011","article-title":"Cogrinding enhances the oral bioavailability of EMD 57033, a poorly water soluble drug, in dogs","volume":"68","author":"Vogt","year":"2008","journal-title":"Euro. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.ejps.2025.107081_bib0038","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1021\/acs.molpharmaceut.5b00688","article-title":"Theoretical considerations of the prigogine\u2013Defay ratio with regard to the glass-forming ability of drugs from undercooled melts","volume":"13","author":"Wyttenbach","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107081_bib0039","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1208\/s12249-021-02005-x","article-title":"Development of Apremilast solid dispersion using TPGS and PVPVA with enhanced solubility and bioavailability","volume":"22","author":"Yang","year":"2021","journal-title":"AAPS. PharmSciTech.."},{"key":"10.1016\/j.ejps.2025.107081_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121516","article-title":"Development of an amorphous based sustained release system for apremilast a selective phosphodiesterase 4 (PDE4) inhibitor","volume":"615","author":"Zhang","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107081_bib0041","article-title":"Systematic thermodynamic analysis of apremilast polymorphs via solubility measurement with modeling: mechanism evaluation through molecular simulation","volume":"165","author":"Zhang","year":"2021","journal-title":"Euro. J. Pharmaceutic. Sci."},{"key":"10.1016\/j.ejps.2025.107081_bib0042","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3390\/pharmaceutics2040419","article-title":"The influence of milling on the dissolution performance of Simvastatin","volume":"2","author":"Zimper","year":"2010","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2025.107081_bib0043","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/pharmaceutics2010030","article-title":"Quantification of process induced disorder in milled samples using different analytical techniques","volume":"2","author":"Zimper","year":"2010","journal-title":"Pharmaceutics."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:07:17Z","timestamp":1760227637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725000806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":43,"alternative-id":["S0928098725000806"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107081","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-milling of glass forming ability class III drugs: Comparing the impact of low and high glass transition temperatures","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107081"}}